Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Sep 25, 2024 02:21PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
YouTube:
I give it 8 out of 10. (pretty good)
https://www.youtube.com/watch?v=pw1Rsm1UR3o
Koo